ATC Group: A02BX02 Sucralfate

Anatomical Therapeutic Chemical Classification System

Hierarchical position in ATC classification

Level
Code
Title
1
Alimentary tract and metabolism
2
Drugs for acid related disorders
3
DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
4
Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
5
A02BX02
Sucralfate

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route
Amount
ORAL - Oral
4 g

Active ingredients

Active Ingredient
Description

Sucralfate forms an ulcer adherent complex with the proteinaceous exudate of the ulcer site. This property enables sucralfate to form a protective barrier over the ulcer lesion giving sustained protection against the penetration and action of gastric acid, pepsin and bile.

Medicines in this ATC group

Drug
Countries

Estonia Finland Italy

New Zealand United States

Ecuador

France

Hong Kong

Hong Kong

Cyprus Estonia

Hong Kong Italy

France Tunisia

South Africa

South Africa

South Africa

Estonia Lithuania Poland

Related product monographs

Title
Type
Country
Structured Product Labeling (SPL)
US